Skip to main content

Drugs

Ausgabe 15/2020

Inhalt (12 Artikel)

Leading Article

Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date

Reda M. Chalhoub, Peter W. Kalivas

Leading Article

Movement of Poly-ADP Ribose (PARP) Inhibition into Frontline Treatment of Ovarian Cancer

Michaela Onstad, Robert L. Coleman, Shannon N. Westin

Open Access Review Article

Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs

N. R. Fuggle, C. Cooper, N. C. Harvey, N. Al-Daghri, M.-L. Brandi, O. Bruyere, A. Cano, E. M. Dennison, A. Diez-Perez, J.-M. Kaufman, S. Palacios, D. Prieto-Alhambra, S. Rozenberg, T. Thomas, F. Tremollieres, R. Rizzoli, J. A. Kanis, J. Y. Reginster

Review Article

Management of Thrombotic Complications in COVID-19: An Update

Adrija Hajra, Sheetal Vasundara Mathai, Somedeb Ball, Dhrubajyoti Bandyopadhyay, Maedeh Veyseh, Sandipan Chakraborty, Carl J. Lavie, Wilbert S. Aronow

Systematic Review

Deprescribing Opioids in Chronic Non-cancer Pain: Systematic Review of Randomised Trials

Stephanie Mathieson, Christopher G. Maher, Giovanni E. Ferreira, Melanie Hamilton, Jesse Jansen, Andrew J. McLachlan, Martin Underwood, Chung-Wei Christine Lin

Correction

Correction to: Deprescribing Opioids in Chronic Non‑cancer Pain: Systematic Review of Randomised Trials

Stephanie Mathieson, Christopher G. Maher, Giovanni E. Ferreira, Melanie Hamilton, Jesse Jansen, Andrew J. McLachlan, Martin Underwood, Chung-Wei Christine Lin

Adis Drug Evaluation

Atezolizumab: A Review in Extensive-Stage SCLC

James E. Frampton

Open Access AdisInsight Report

Triheptanoin: First Approval

Matt Shirley

AdisInsight Report

Bulevirtide: First Approval

Connie Kang, Yahiya Y. Syed

AdisInsight Report

Belantamab Mafodotin: First Approval

Anthony Markham

Correction

Correction to: Fostemsavir: First Approval

Anthony Markham

Aktuelle Ausgaben